Financial News
Aldeyra Therapeu (NQ: ALDX )
4.150
+0.060
(+1.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about Aldeyra Therapeu
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230809204247/en/765953/22/Close_Up_Logo_HD_Blue.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Expert Ratings for Aldeyra Therapeutics
August 09, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230808787939/en/805463/22/business_Wire_Robbins_LLP.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for Aldeyra Therapeutics
June 22, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230808369356/en/478343/5/GPM_Logo_Colo.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://mms.businesswire.com/media/20230807253809/en/538768/22/BES_Mark.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://mms.businesswire.com/media/20230803053004/en/478343/5/GPM_Logo_Colo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230803114369/en/765953/22/Close_Up_Logo_HD_Blue.jpg)
![](https://mms.businesswire.com/media/20230802477975/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
![](https://mms.businesswire.com/media/20230801904511/en/805463/22/business_Wire_Robbins_LLP.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230629018435/en/1831373/22/download.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2023/06/27/aldx.png?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/21/aldx.png?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Aldeyra Therapeutics
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/06/15/john_wiley__sons_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/15/aldx.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.